Found: 17
Select item for more details and to access through your institution.
Long‐term cardiac, vascular, hypertension, and effusion safety of bosutinib in patients with Philadelphia chromosome–positive leukemia resistant or intolerant to prior therapy.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 6, p. 808, doi. 10.1111/ejh.13608
- By:
- Publication type:
- Article
Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S290, doi. 10.1016/j.clml.2019.07.235
- By:
- Publication type:
- Article
Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S294, doi. 10.1016/j.clml.2019.07.243
- By:
- Publication type:
- Article
Effects of Bosutinib Treatment on Renal Function in Patients With Philadelphia Chromosome-Positive Leukemias.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bosutinib (BOS) vs Imatinib (IM) for Newly Diagnosed Chronic Myeloid Leukemia (CML): Initial Results from the BFORE Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S316, doi. 10.1016/j.clml.2017.07.117
- By:
- Publication type:
- Article
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 12, p. 1206, doi. 10.1002/ajh.24536
- By:
- Publication type:
- Article
Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 606, doi. 10.1002/ajh.24360
- By:
- Publication type:
- Article
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 97, doi. 10.1111/bjh.13801
- By:
- Publication type:
- Article
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 755, doi. 10.1002/ajh.24034
- By:
- Publication type:
- Article
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 7, p. 732, doi. 10.1002/ajh.23728
- By:
- Publication type:
- Article
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 346, doi. 10.1634/theoncologist.2014-0022
- By:
- Publication type:
- Article
Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer.
- Published in:
- Oncologist, 2014, v. 19, n. 4, p. 348, doi. 10.1634/theoncologist.2014-0021
- By:
- Publication type:
- Article
Glycemic status and development of kidney disease: the Framingham Heart Study.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Glycemic Status and Development of Kidney Disease.
- Published in:
- Diabetes Care, 2005, v. 28, n. 10, p. 2436, doi. 10.2337/diacare.28.10.2436
- By:
- Publication type:
- Article
Predictors of New-Onset Kidney Disease in a Community-Based Population.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 7, p. 844, doi. 10.1001/jama.291.7.844
- By:
- Publication type:
- Article
Competing risks for first cardiovascular events after hypertension onset: the Framingham Heart Study
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study.
- Published in:
- JAMA: Journal of the American Medical Association, 2002, v. 288, n. 10, p. 1252, doi. 10.1001/jama.288.10.1252
- By:
- Publication type:
- Article